Immunity to the group A streptococcus has been shown to be associated with the formation of antibody against the type-specific component of the streptococcus, the M protein of Lancefield (1, 2). The techniques that have been employed in studies of this antibody include agglutination (3), precipitation (4), mouse protection (5), and bacteriostasis (6, 7). For practical purposes, in the study of human infections, all of these methods except the bacteriostatic test have proved to be unsatisfactory. The latter test, as described by Rothbard (7), yields reliable results but the numerous technical difficulties inherent in the procedure have made it desirable to find another method for the demonstration of type specific antibodies.
Immunity to the group A streptococcus has been shown to be associated with the formation of antibody against the type-specific component of the streptococcus, the M protein of Lancefield (1, 2) . The techniques that have been employed in studies of this antibody include agglutination (3), precipitation (4), mouse protection (5), and bacteriostasis (6, 7) . For practical purposes, in the study of human infections, all of these methods except the bacteriostatic test have proved to be unsatisfactory. The latter test, as described by Rothbard (7) , yields reliable results but the numerous technical difficulties inherent in the procedure have made it desirable to find another method for the demonstration of type specific antibodies.
The presence of various antibodies has been demonstrated by the adsorption of antigenic components of bacteria to the surface of erythrocytes, rendering the cells agglutinable by specific antisera. The widest application of this technique has been in the demonstration of antibodies to a component of the tubercle bacillus (8, 9) ; the technique has also been applied in serological studies of H. influenzal meningitis (10) , histoplasmosis (11) , glanders (12) , scrub typhus (13) , mumps (14) , tularemia (15) , streptococcal infections and rheumatic fever (16) , and infections with E. coli (17) .
In this laboratory, repeated attempts were made to adsorb M posed to high concentrations of the antigen for prolonged periods. Other methods were then sought which would modify the cell surface and facilitate the adsorption of M protein. Peck and Thomas (18) , in a study of the capacity of tannic acid to render erythrocytes susceptible to hemolysis by human complement, demonstrated that tannic acid has an apparent affinity for both red cells and complement, and when adsorbed on the cell surface is capable of bringing complement, or a component of complement, into close relation with the cell surface. The concentration of saline used as a diluent was of major importance, 0.7 per cent saline proved to be optimal. Human red cells treated with tannic acid were not susceptible to lysis by sera from. the rabbit, guinea pig, mouse, or sheep. Boyden (19) , by treating sheep erythrocytes with tannic acid prior to adsorbing P.P.D. antigen to their surfaces, was able to detect antibodies in sera from tuberculous patients in dilutions up to 100-fold greater than those shown by the direct sensitization technique of Middlebrook and Dubos (8) . The results of the two methods, however, did not always correlate and the author suggests that more than one antibody may have been involved. By the same technique ovalbumin, horse serum globulin and albumin, chicken globulin, and a streptococcus protein preparation were adsorbed to sheep red cells, and the cells were agglutinated by the corresponding antibodies.
The present paper is concerned with the demonstration of type-specific antibodies against the M protein of group A streptococci, by a hemagglutination reaction involving human erythrocytes treated with tannic acid prior to the adsorption of M antigen.
MATERIALS AND METHODS
Hulmant erythrocytes. Human group 0 blood was collected aseptically in equal volumes of Alsever's solution (20) and stored at 40 C. The erythrocytes so stored could be used for several weeks. At the beginning of each day an aliquot of cells was washed three times in normal saline and was then ready for use. Satisfactory results were also obtained with group 0 blood-bank cells which had been collected within the preceding several days. When blood bank cells were used they were collected by centrifugation and added to equal volumes of Alsever's solution.
Saline solution. Saline solution was used in a concentration of 0.75 per cent in all parts of the procedure except in the initial washing of the erythrocytes. The Controls were run with all tests and included erytlirocytes treated with tannic acid and M protein with no serum present, and erythrocytes treated with tannic acid alone.
Hemolytic test. The hemagglutination test could, under certain conditions described below, be converted into one involving hemolysis instead of agglutination. This was accomplished by adding to each tube in the agglutination test, after overnight refrigeration, 0.2 cc. of a 1: 5 dilution of guinea pig complement. Readings for hemolysis were made after 1 hour in the 37°C. water bath.
EXPERIMENTAL RESULTS
The optimal concentration of tannic acid. Since hemagglutination is known to occur in the presence of tannic acid alone, it was first necessary to determine the concentrations of this material which could be used without causing agglutination. To do this, various concentrations of tannic acid were added to a 1 per cent solution of washed red cells, in the proportion of one volume of tannic acid to two of cell suspension. The mixture was allowed to stand at room temperature for 30 minutes, and the cells washed three times. The erythrocytes were then resuspended in 0.75 per cent saline to make a 1 per cent suspension, placed in the refrigerator overnight, and read for agglutination. Definite agglutination occurred in cell suspensions which had been exposed to tannic acid in concen- The hemolytic effect of guinea pig complement on treated cells in the presence of specific antiserum. It has been shown that tannic acid-treated human erythrocytes are hemolyzed by human complement, but not by guinea pig complement (18) . Accordingly, attempts were made to determine if guinea pig complement, when added to the regular test, would change it to one that could be read by hemolysis instead of hemagglutination. Guinea pig complement was added to the tubes containing the mixtures of M-sensitized cells and antiserum, after the latter had been allowed to stand overnight at 40 C. After the addition of complement the cells were incubated at 370 C. for one hour and then read for hemolysis. When preparations of type 24 M protein were used, hemolysis occurred in significant titers. Little or no hemolysis occurred, however, even when the hemagglutinating titers were high, when types 1, 3, 5, and 14 M protein and antisera were used. The sensitivity of the hemolytic test using type 24 M protein varied with different batches of the antigen but in all instances showed higher titers than were seen with preparations made from other types of streptococci. The hemolysis seemed to be specific in that none occurred in the absence of specific hemagglutination.
The specific inhibition of hemagglutination by for the homologous antigen. No hemagglutination occurred with either the acute-phase or convalescent serum of one patient.
Table IV also shows that reactions of the same pairs of sera occurred with erythrocytes treated with type 14 M protein. Hemagglutination was noted in four of the six pairs of sera; there was an increase in titer with one pair of sera while the other three showed the same titers in the acutephase and convalescent sera.
Acute and convalescent phase sera from patients with infections due to types 1, 5, 14, and 24 streptococci have also been tested for the presence of hemagglutinating antibodies. Significant increases have been demonstrated in the convalescent sera in the majority of cases with the homologous type of M protein. In addition, however, nonspecific cross reactions similar to those described above were encountered in a high percentage of cases.
In most instances there was direct correlation between the presence of type-specific bactericidal antibodies and type-specific hemagglutinating antibodies. In several cases, however, hemagglutination did not occur with sera known to contain bactericidal antibody, suggesting the possibility that the antibodies responsible for the two reactions may not be identical.
The blocking effect of heterologous M preparations on nonspecific cross-reactions. The occurrence of nonspecific cross-reactions in the hemagglutination test with human sera might be explained by the presence of antibodies other than anti-M, presumably reacting with contaminating antigenic materials contained in the crude M preparations. Attempts to circumvent this difficulty by employing a more highly purified M preparation, supplied by Dr. Lancefield, were unsuccessful. Therefore, the possible blocking effect of heterologous M preparations on the cross-reactions was investigated. An illustrative experiment in which this was accomplished, and cross-reactions eliminated, is shown in Table V . The serum was from a patient convalescent from a type 24 streptococcal infection and contained bactericidal antibodies to type 24 streptococcus but not to type 14 streptococcus; there were, however, hemagglutinating antibodies reacting with both types. When 0.2 cc. of a 1: 100 dilution of type 3 M protein was added to each tube, and the tubes incubated at 370 C. for one hour before the addition of the M proteintreated erythrocytes, the titer of type 24 antibodies was not altered but the reaction with cells treated with type 14 M was markedly inhibited.
Some preparations of M protein were more effective than others in the inhibition of nonspecific hemagglutination; one batch of type 3 M protein has been the most effective in experiments performed to this time. It should be noted that this batch of M protein apparently contains a large amount of non-M antigen since it has been associated with many nonspecific reactions when adsorbed to erythrocytes and tested with heterologous sera.
Boyden (19) reported that the stability of tannic-acid treated cells was improved by the use of normal rabbit serum in the diluting fluid. The effect of using 1 per cent rabbit serum in 0.75 per cent saline as the diluent for antiserum was therefore investigated in experiments dealing with the blocking effect of heterologous M protein. It was found that the degree of agglutination was much enhanced in mixtures of antisera with homologous M antigen, and the elimination of cross-reactions by blocking with heterologous M preparations was made more clear cut. The improvement of the test by normal rabbit serum is illustrated in Table  V .
These methods for improving the specificity of the test are now being applied in tests of sera from patients with streptococcal infections and rheumatic fever, to be reported in a subsequent communication. DISCUSSION Attempts to bring about the adsorption of M protein to the surface of human erythrocytes, for the purpose of demonstrating anti-M protein antibody by hemagglutination, were unsuccessful when untreated red cells were employed. Kirby (16) , in a study of the hemagglutination reaction with a mixture of streptococcal antigenic materials, was also unable to produce type-specific reactions indicating the presence of M protein on the erythrocytes.
The treatment of human group 0 erythrocytes with small amounts of tannic acid has made possible the adsorption to the cell surface of the M protein of group A streptococci. Erythrocytes so treated are selectively agglutinated by antistreptococcus rabbit sera and by the sera of humans convalescent from streptococcal infections. In the tests with human sera, however, non-specific crossreactions with other types of M have occurred in a sufficiently high percentage of cases to make the use of the test, without modification, impractical.
The non-specific hemagglutination appeared to be due to an antibody reacting with unidentified antigenic material contained in the M protein preparations. The titer of this antibody did not appear to be related to the titer of specific M antibody. In some cases increased levels of both kinds of antibody were demonstrated in convalescent sera; in others, however, there was a rise in specific M antibody while both the acute-phase and convalescent sera showed equally high titers of heterologous hemagglutinating antibody.
The non-specific cross-reactions could be in-hibited by the addition of a heterologous M preparation to the serum before mixing the latter with M-treated erythrocytes. Some batches -of M were more effective than others; the more effective batches were those that seemed to contain relatively large amounts of non-specific antigenic material. The amount of heterologous antigen required to block cross-reactions was sometimes difficult to determine without detailed titrations, because of the occurrence of spontaneous agglutination in the presence of excess M protein. The addition of normal rabbit serum to the diluent considerably improved the test; specific agglutination was enhanced, and the inhibition of non-specific agglutination by heterologous M-preparations was more clear-cut. Studies are now in progress to determine if the test can be made practical for routine use by these modifications.
A possible solution to some of the problems in the hemagglutination test was the conversion of the test, by the addition of guinea pig complement, to one read by hemolysis. Attempts to do this were disappointing, since significant degrees of hemolysis occurred only in tests in which type 24 protein and antibody were employed. The reason for the failure to show hemolysis with tests involving other types of antigen and antibody is not known.
Much care was necessary in the treatment of erythrocytes with tannic acid and M protein. The spontaneous agglutination due to tannic acid could be prevented by determining the agglutinating property of each lot of tannic acid before use. It was more difficult to select the concentration of M protein that did not cause agglutination of the erythrocytes but was adsorbed in sufficient quantities to react with antibody. In using specific rabbit anti-sera this was not a great problem; the M antibodies were of such high levels that erythrocytes treated with very small amounts of antigen were agglutinated. With human sera, however, it was desirable to use as great a concentration of antigen as possible without causing spontaneous agglutination, in order to detect small amounts of antibody. Each batch of M protein required, therefore, detailed titrations to determine the optimal amounts for the, preparation of sensitized cells. SUMMARY 1. M Protein of group A streptococci was adsorbed to human group 0 erythrocytes previously exposed to small amounts of tannic acid, and these cells were specifically agglutinated by homologous rabbit antistreptococcus sera and sera of some patients convalescent from streptococcal infection.
2. The addition of guinea pig complement to the hemagglutination test resulted in significant specific hemolysis when type 24 M protein and antiserum were used; little or no hemolysis occurred when other types of M protein and antisera were involved.
3. Hemagglutination was specifically inhibited by the addition of homologous M protein to the serum before the addition of the M protein-sensitized erythrocytes.
4. In a study of human sera the appearance of type-specific hemagglutinins was demonstrated during convalescence from streptococcal infection. However, non-specific hemagglutination was frequently encountered. This could be inhibited in some instances by incubating the serum with a heterologous M preparation before the addition of the treated erythrocytes. Specific agglutination, and the inhibition of non-specific agglutination by heterologous M protein, were made more clearcut by the use of normal rabbit serum in the diluting fluid.
